NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

NCT00910741 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced and Metastatic Pancreatic Cancer

Interventions

DRUG: Nanoplatin (NC-6004) and Gemcitabine

Sponsor

NanoCarrier Co., Ltd.

Collaborators

[object Object]